Skip to main content

Business

By Anthony Vecchione | 02:46 pm | August 07, 2025
The company said it plans to develop its new Chai‑2 platform to design, from square one, completely new antibodies for viruses and cancer.
By Anthony Vecchione | 12:51 pm | August 07, 2025
The acquisition will help Datavant transition its manual health records request process to digital.
By HIMSS TV | 09:00 am | August 07, 2025
Data reveals that the people who are enrolling in Medicare Advantage have 50% more chronic conditions than people who are enrolling in Medicare fee-for-service, says Christie Teigland, Inovalon's VP of research science and advanced analytics.
By Anthony Vecchione | 12:40 pm | August 06, 2025
The company intends to partner with healthcare, biopharmaceutical, medical device and diagnostic companies.
By Jessica Hagen | 11:32 am | August 06, 2025
The company began trading on the NYSE in May and saw an increase in its stock price upon the news of its second-quarter earnings.
By HIMSS TV | 10:48 am | August 06, 2025
Clinicians need to have integrity with how they present AI tools to their teams, focusing on how those tools can solve problems, says Josh Wymer, chief health information and data strategy officer at the Missouri Department of Health and Senior Services.
By Anthony Vecchione | 03:00 pm | August 05, 2025
The company aims to help providers secure stable pricing and access products and services for patients seeking reproductive and sexual healthcare.
By Anthony Vecchione | 02:22 pm | August 05, 2025
The company will use the funds to scale its reach within the U.S. and to expand access to its offerings globally.
By Jessica Hagen | 01:26 pm | August 05, 2025
The acquisition comes just months after Cerebral reached a settlement with the FTC over allegations of deceptive subscription and data-sharing practices.
By HIMSS TV | 11:00 am | August 05, 2025
When implementing AI-powered assistants and ambient technologies, it is essential to know if what you are buying is an actual assistant and if it has features beyond just clinical documentation, says Punit Soni, founder and CEO of Suki.